Abstract
Introduction
Patients undergoing bariatric surgery experience substantial risk of pre- and postoperative substance use. Identifying patients at risk for substance use using validated screening tools remains crucial to risk mitigation and operative planning. We aimed to evaluate proportion of bariatric surgery patients undergoing specific substance abuse screening, factors associated with screening and the relationship between screening and postoperative complications.
Methods
The 2021 MBSAQIP database was analyzed. Bivariate analysis was performed to compare factors between groups who were screened for substance abuse versus non-screened, and to compare frequency of outcomes. Multivariate logistic regression analysis was performed to assess the independent effect of substance screening on serious complications and mortality, and to assess factors associated with substance abuse screening.
Results
A total of 210, 804 patients were included, with 133,313 (63.2%) undergoing screening and 77,491 (36.8%) who did not. Those who underwent screening were more likely to be white, non-smoker, and have more comorbidities. The frequency of complications was not significant (e.g., reintervention, reoperation, leak) or similar (readmission rates 3.3% vs. 3.5%) between screened and not screened groups. On multivariate analysis, lower substance abuse screening was not associated with 30-day death or 30-day serious complication. Factors that significantly affected likelihood of being screened for substance abuse included being black (aOR 0.87, p < 0.001) or other race (aOR 0.82, p < 0.001) compared to white, being a smoker (aOR 0.93, p < 0.001), having a conversion or revision procedure (aOR 0.78, p < 0.001; aOR 0.64, p < 0.001, respectively), having more comorbidities and undergoing Roux-en-y gastric bypass (aOR 1.13, p < 0.001).
Conclusion
There remains significant inequities in substance abuse screening in bariatric surgery patients regarding demographic, clinical, and operative factors. These factors include race, smoking status, presence of preoperative comorbidities, and procedure type. Further awareness and initiatives highlighting the importance of identifying at risk patients is critical for ongoing outcome improvement.
Graphical abstract
Similar content being viewed by others
References
Chang SH, Stoll CR, Song J, Varela JE, Eagon CJ, Colditz GA (2014) The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003–2012. JAMA Surg 149(3):275–287. https://doi.org/10.1001/jamasurg.2013.3654
Li L, Wu LT (2016) Substance use after bariatric surgery: a review. J Psychiatr Res 76:16–29. https://doi.org/10.1016/j.jpsychires.2016.01.009
Conason A, Teixeira J, Hsu CH, Puma L, Knafo D, Geliebter A (2013) Substance use following bariatric weight loss surgery. JAMA Surg 148(2):145–150. https://doi.org/10.1001/2013.jamasurg.265
Wiedemann AA, Saules KK, Ivezaj V (2013) Emergence of New Onset substance use disorders among post-weight loss surgery patients. Clin Obes 3(6):194–201. https://doi.org/10.1111/cob.12034
King WC, Chen JY, Courcoulas AP, Dakin GF, Engel SG, Flum DR et al (2017) Alcohol and other substance use after bariatric surgery: prospective evidence from a US multicenter cohort study. Surg Obes Relat Dis 13(8):1392–1402. https://doi.org/10.1016/j.soard.2017.03.021
Ivezaj V, Saules KK, Schuh LM (2014) New-onset substance use disorder after gastric bypass surgery: rates and associated characteristics. Obes Surg 24(11):1975–1980. https://doi.org/10.1007/s11695-014-1317-8
Nasser K, Verhoeff K, Mocanu V, Kung JY, Purich K, Switzer NJ et al (2022) New persistent opioid use after bariatric surgery: a systematic review and pooled proportion meta-analysis. Surg Endosc. https://doi.org/10.1007/s00464-022-09291-x
Adams CE, Gabriele JM, Baillie LE, Dubbert PM (2012) Tobacco use and substance use disorders as predictors of postoperative weight loss 2 years after bariatric surgery. J Behav Health Serv Res 39(4):462–471. https://doi.org/10.1007/s11414-012-9277-z
World Health Organization (2020) Tobacco and postsurgical outcomes. https://apps.who.int/iris/bitstream/handle/10665/330485/9789240000360-eng.pdf.
Compton WM, Han B (2022) Substance use disorders are deadly. Am J Psychiatry 179(1):11–13. https://doi.org/10.1176/appi.ajp.2021.21101069
Ali GC, Ryan G, De Silva MJ (2016) Validated screening tools for common mental disorders in low and middle income countries: a systematic review. PLoS ONE 11(6):e0156939. https://doi.org/10.1371/journal.pone.0156939
World Health Organization ASSIST Working Group (2002) The alcohol, smoking and substance involvement screening test (ASSIST): development, reliability and feasibility. Addiction 97(9):1183–1194. https://doi.org/10.1046/j.1360-0443.2002.00185.x
Ward EN, Quaye AN, Wilens TE (2018) Opioid Use disorders: perioperative management of a special population. Anesth Analg 127(2):539–547. https://doi.org/10.1213/ANE.0000000000003477
Englander H, Dobbertin K, Lind BK, Nicolaidis C, Graven P, Dorfman C et al (2019) Inpatient addiction medicine consultation and post-hospital substance use disorder treatment engagement: a propensity-matched analysis. J Gen Intern Med 34(12):2796–2803. https://doi.org/10.1007/s11606-019-05251-9
Pulley DD (2016) Preoperative evaluation of the patient with substance use disorder and perioperative considerations. Anesthesiol Clin 34(1):201–211. https://doi.org/10.1016/j.anclin.2015.10.015
American College of Surgeons (2022) MBSAQIP User Guide for the 2021 Participant Use Data File (PUF). https://www.facs.org/media/krbickhz/mbsaqip_puf_userguide_2021.pdf. Accessed November 2022.
American College of Surgeons. MBSAQIP Operations Manual Chapter 4 Procedural Risk Factors: Substance Abuse Screening Completed. http://cqi.facs.org/operationsmanual/mbsaqip/Variables/Substance_Abuse_Screening_Complete.htm Accessed November 2022.
Carter J, Chang J, Birriel TJ, Moustarah F, Sogg S, Goodpaster K et al (2021) ASMBS position statement on preoperative patient optimization before metabolic and bariatric surgery. Surg Obes Relat Dis 17(12):1956–1976. https://doi.org/10.1016/j.soard.2021.08.024
Sogg S, Lauretti J, West-Smith L (2016) Recommendations for the presurgical psychosocial evaluation of bariatric surgery patients. Surg Obes Relat Dis 12(4):731–749. https://doi.org/10.1016/j.soard.2016.02.008
King WC, Chen JY, Mitchell JE, Kalarchian MA, Steffen KJ, Engel SG et al (2012) Prevalence of alcohol use disorders before and after bariatric surgery. JAMA 307(23):2516–2525. https://doi.org/10.1001/jama.2012.6147
Tedesco M, Hua WQ, Lohnberg JA, Bellatorre N, Eisenberg D (2013) A prior history of substance abuse in veterans undergoing bariatric surgery. J Obes 2013:740312. https://doi.org/10.1155/2013/740312
Heinberg LJ, Ashton K, Coughlin J (2012) Alcohol and bariatric surgery: review and suggested recommendations for assessment and management. Surg Obes Relat Dis 8(3):357–363. https://doi.org/10.1016/j.soard.2012.01.016
Kanji S, Wong E, Akioyamen L, Melamed O, Taylor VH (2019) Exploring pre-surgery and post-surgery substance use disorder and alcohol use disorder in bariatric surgery: a qualitative scoping review. Int J Obes (Lond) 43(9):1659–1674. https://doi.org/10.1038/s41366-019-0397-x
Ashton K, Heinberg L, Merrell J, Lavery M, Windover A, Alcorn K (2013) Pilot evaluation of a substance abuse prevention group intervention for at-risk bariatric surgery candidates. Surg Obes Relat Dis 9(3):462–467. https://doi.org/10.1016/j.soard.2013.01.016
Edwards DA, Hedrick TL, Jayaram J, Argoff C, Gulur P, Holubar SD et al (2019) American society for enhanced recovery and perioperative quality initiative joint consensus statement on perioperative management of patients on preoperative opioid therapy. Anesth Analg 129(2):553–566. https://doi.org/10.1213/ANE.0000000000004018
Thomsen T, Villebro N, Moller AM (2014) Interventions for preoperative smoking cessation. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD002294.pub4
Wong J, Lam DP, Abrishami A, Chan MT, Chung F (2012) Short-term preoperative smoking cessation and postoperative complications: a systematic review and meta-analysis. Can J Anaesth 59(3):268–279. https://doi.org/10.1007/s12630-011-9652-x
Alizadeh S, Mahmoudi GA, Solhi H, Sadeghi-Sedeh B, Behzadi R, Kazemifar AM (2015) Post-operative analgesia in opioid dependent patients: comparison of intravenous morphine and sublingual buprenorphine. Addict Health 7(1–2):60–65
Sayal P, Bateman BT, Menendez M, Eikermann M, Ladha KS (2018) Opioid Use disorders and the risk of postoperative pulmonary complications. Anesth Analg 127(3):767–774. https://doi.org/10.1213/ANE.0000000000003307
Lin A, Verhoeff K, Mocanu V, Purich K, Nasser K, Kung JY et al (2022) Opioid prescribing practices following bariatric surgery: a systematic review and pooled proportion meta-analysis. Surg Endosc. https://doi.org/10.1007/s00464-022-09481-7
Smith ME, Lee JS, Bonham A, Varban OA, Finks JF, Carlin AM et al (2019) Effect of new persistent opioid use on physiologic and psychologic outcomes following bariatric surgery. Surg Endosc 33(8):2649–2656. https://doi.org/10.1007/s00464-018-6542-0
Hagedorn JC, Encarnacion B, Brat GA, Morton JM (2007) Does gastric bypass alter alcohol metabolism? Surg Obes Relat Dis 3(5):543–548. https://doi.org/10.1016/j.soard.2007.07.003
Parikh M, Johnson JM, Ballem N, American Society for M, Bariatric Surgery Clinical Issues C (2016) ASMBS position statement on alcohol use before and after bariatric surgery. Surg Obes Relat Dis 12(2):225–230. https://doi.org/10.1016/j.soard.2015.10.085
Woodard GA, Downey J, Hernandez-Boussard T, Morton JM (2011) Impaired alcohol metabolism after gastric bypass surgery: a case-crossover trial. J Am Coll Surg 212(2):209–214. https://doi.org/10.1016/j.jamcollsurg.2010.09.020
Klockhoff H, Naslund I, Jones AW (2002) Faster absorption of ethanol and higher peak concentration in women after gastric bypass surgery. Br J Clin Pharmacol 54(6):587–591. https://doi.org/10.1046/j.1365-2125.2002.01698.x
Ungur AL, Neumann T, Borchers F, Spies C (2020) Perioperative management of alcohol withdrawal syndrome. Visc Med 36(3):160–166. https://doi.org/10.1159/000507595
Jordan A, Babuscio T, Nich C, Carroll KM (2021) A feasibility study providing substance use treatment in the Black church. J Subst Abuse Treat 124:108218. https://doi.org/10.1016/j.jsat.2020.108218
Matsuzaka S, Knapp M (2020) Anti-racism and substance use treatment: Addiction does not discriminate, but do we? J Ethn Subst Abuse 19(4):567–593. https://doi.org/10.1080/15332640.2018.1548323
Santoro TN, Santoro JD (2018) Racial bias in the US opioid epidemic: a review of the history of systemic bias and implications for care. Cureus 10(12):e3733. https://doi.org/10.7759/cureus.3733
Enzinger AC, Ghosh K, Keating NL, Cutler DM, Clark CR, Florez N et al (2023) Racial and ethnic disparities in opioid access and urine drug screening among older patients with poor-prognosis cancer near the end of Life. J Clin Oncol. https://doi.org/10.1200/JCO.22.01413
Hoffman KM, Trawalter S, Axt JR, Oliver MN (2016) Racial bias in pain assessment and treatment recommendations, and false beliefs about biological differences between blacks and whites. Proc Natl Acad Sci U S A 113(16):4296–4301. https://doi.org/10.1073/pnas.1516047113
Weinberger AH, Platt J, Esan H, Galea S, Erlich D, Goodwin RD (2017) Cigarette smoking is associated with increased risk of substance use disorder relapse: a nationally representative prospective longitudinal investigation. J Clin Psychiatry 78(2):e152–e160. https://doi.org/10.4088/JCP.15m10062
Fogger SA, McGuinness TM (2012) The relationship between addictions and bariatric surgery for nurses in recovery. Perspect Psychiatr Care 48(1):10–15. https://doi.org/10.1111/j.1744-6163.2010.00298.x
Saules KK, Wiedemann A, Ivezaj V, Hopper JA, Foster-Hartsfield J, Schwarz D (2010) Bariatric surgery history among substance abuse treatment patients: prevalence and associated features. Surg Obes Relat Dis 6(6):615–621. https://doi.org/10.1016/j.soard.2009.12.008
Reslan S, Saules KK, Greenwald MK, Schuh LM (2014) Substance misuse following Roux-en-Y gastric bypass surgery. Subst Use Misuse 49(4):405–417. https://doi.org/10.3109/10826084.2013.841249
Funding
No funding to be disclosed.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
None of the authors of this manuscript, including Sukhdeep Jatana, Kevin Verhoeff, Valentin Mocanu, Uzair Jogiat, Daniel W. Birch, Noah J. Switzer, and Shahzeer Karmali, have any disclosures.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Jatana, S., Verhoeff, K., Mocanu, V. et al. Substance abuse screening prior to bariatric surgery: an MBSAQIP cohort study evaluating frequency and factors associated with screening. Surg Endosc 37, 5303–5312 (2023). https://doi.org/10.1007/s00464-023-10026-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-023-10026-9